• Adastra Labs (XTRX) has entered into a split tolling agreement with fellow cannabis company, Muskoka Grown
  • Under the agreement, Muskoka Grown will provide the company with cannabis biomass for toll processing into distillate
  • Adastra Labs and Muskoka Grown will share the high-grade cannabis distillate which is produced from the processing
  • To date, the company has already received 900 kilograms of cannabis flower and trim from Muskoka Gown for processing
  • Adastra Labs (XTRX) is down 1.11 per cent and is currently trading at C$0.89 per share

Adastra Labs (XTRX) has entered into a split tolling agreement with fellow cannabis company, Muskoka Grown.

Under the terms of the agreement, Muskoka Grown is providing Adastra Labs with cannabis biomass, which the company will process into distillate. Adastra is able to produce cannabis extract through carbon dioxide extraction and secondary distillation.

Extracts and distillates can be incorporated into a variety of Cannabis 2.0 products. These include edibles, beverages, topicals, tinctures, vape cartridges, and others.

Adastra Labs and Muskoka Grown will share the high-grade cannabis distillate which is produced from the processing.

Adastra Labs’ CEO, Andy Hale, commented on how the companies’ agreement is progressing thus far.

“We are pleased to have received two shipments from Muskoka Grown, a small-batch high-quality cannabis cultivator. 

“We are fortunate to be able to leverage Muskoka Grown’s quality growing with over 900 kilograms of quality cannabis flower and trim received to date under a split tolling agreement.

“Muskoka Grown’s cannabis has been producing high-quality distillate, and we look forward to continuing this tolling agreement,” he said.

Muskoka Grown’s founder and CEO, David Grand, also commented on the agreement, and the benefits it has brought to the company.

“While Muskoka Grown remain focused on producing freshly packaged dried products, we are thrilled to provide out high-grade cannabis as biomass for processing.

“We value this strategic partnership that has allowed us an opportunity to expand our revenue streams,” he said.

Adastra Labs (XTRX) is down 1.11 per cent and is trading at C$0.89 per share at 3:16pm EDT.

More From The Market Online
Cannabis Report image of farmed cannabis plants

The Market Online’s Weekly Cannabis Report – July 26, 2024

Tilray Oral Solution THC10:CBD10 cannabis extract, aka Tilray Solução Oral THC10:CBD10, has been approved for medical use in Portugal.
medical branch logo

Tilray approved for third medical cannabis product in Portugal

Tilray Medical, a subsidiary of Tilray Brands (TSX:TLRY) has been approved for a new medical cannabis extract in Portugal.